LORIS MURDOCK-JOHNSON: Open Payments
NPI 1316583024 · PRINCETON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,383 in 12 payments from 8 companies in 2025. Trend: 2023 $150 · 2024 $500 · 2025 $1,383
Food & beverage: $1,383
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $449 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $220 |
| Alkermes, Inc. | 1 | $127 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| Janssen Pharmaceuticals, Inc | 1 | $120 |
| E.R. Squibb & Sons, L.L.C. | 1 | $114 |
| ABBVIE INC. | 1 | $106 |
Products named: REXULTI, CAPLYTA, LYBALVI, UZEDY, INGREZZA, SPRAVATO, COBENFY, ABILIFY ASIMTUFII.
Industry payments across NJ — which companies pay providers there.
